Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • “If you don’t read about your money, your money will not take care of you”: 7 investing lessons from top fund managers
    • Betashares launches AI ETF to complete trade exposure
    • Ether Slides 26% in a Month to Test $1,700 as ETF Outflows Swell and Whales Buy — BigGo Finance
    • Bring a touch of fairytale magic to your little one’s crunch and sip with The Somewhere Co’s Black Friday sale
    • Can Indian hospitals make AI investments pay?
    • Under-threat lidos get lifeline as Andy Burnham sets up fund to rebuild pools | Swimming
    • Activist Hedge Funds Walked Away From Dick’s After A Profit Warning
    • Robert Pattinson is the new James Bond, and the internet is shaken
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»Bonds»Mankind Pharma Issues Debut Bonds To Fund Major Acquisition
    Bonds

    Mankind Pharma Issues Debut Bonds To Fund Major Acquisition

    October 15, 2024


    What’s going on here?

    Mankind Pharma has tapped into the bond market for the first time, securing $595 million to fund its acquisition of Bharat Serums and Vaccines.

    What does this mean?

    Mankind Pharma’s inaugural bond issuance is a strategic step to efficiently finance its purchase of Bharat Serums and Vaccines, a deal worth 136.30 billion rupees. The issuance drew significant interest from major Indian mutual funds and insurance companies, reflecting confidence in Mankind’s solid ‘AA+’ credit rating. This high rating enabled attractive coupon rates of 7.99% and 7.97% for short- and long-term maturities respectively, indicating a favorable outlook for investors. Arranged by Deutsche Bank and Barclays, this move underscores a robust financial strategy aimed at bolstering Mankind Pharma’s competitive edge in the pharmaceutical sector.

    Why should I care?

    For markets: A strong vote of confidence.

    The participation of major investors like ICICI Prudential and HDFC highlights strong market confidence in Mankind Pharma’s strategy. The favorable rating and substantial backing emphasize the company’s potential for growth and stability, suggesting a ripple effect of optimism across the pharmaceutical sector.

    The bigger picture: India’s growing pharma landscape.

    Mankind Pharma’s aggressive acquisition approach and successful bond issuance signal significant progress in India’s pharmaceutical landscape. As Indian pharmaceuticals continue to expand and consolidate, international investors might focus on this burgeoning market, potentially driving more global investments and partnerships.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    Robert Pattinson is the new James Bond, and the internet is shaken

    November 17, 2026

    Why I, who thought ‘zero interest rates make it unattractive,’ bought Japanese government bonds for the first time|minemaki

    November 16, 2026

    ASOS Buys Back £90m of Convertible Bonds

    November 16, 2026
    Leave A Reply Cancel Reply

    Top Posts

    “If you don’t read about your money, your money will not take care of you”: 7 investing lessons from top fund managers

    November 17, 2026

    ETFs Are Buying Tesla (TSLA) on Nov. 12

    November 16, 2026

    Betashares launches AI ETF to complete trade exposure

    November 17, 2026

    VOYA GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND, VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

    November 16, 2026
    Don't Miss
    Mutual Funds

    “If you don’t read about your money, your money will not take care of you”: 7 investing lessons from top fund managers

    November 17, 2026

    With more investment options being available, choosing among mutual funds, PMS, AIFs, ETFs and direct…

    Betashares launches AI ETF to complete trade exposure

    November 17, 2026

    Ether Slides 26% in a Month to Test $1,700 as ETF Outflows Swell and Whales Buy — BigGo Finance

    November 17, 2026

    Bring a touch of fairytale magic to your little one’s crunch and sip with The Somewhere Co’s Black Friday sale

    November 17, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    All It Takes Is $7,000 Invested in Each of These 5 High-Yield ETFs to Help Generate Over $2,000 in Passive Income Per Year

    September 20, 2025

    Monzo launches ETF investing | MoneyWeek

    June 17, 2025

    UAS Maker Tekever Secures More Investments, Plans Acquisitions

    September 23, 2026
    Our Picks

    “If you don’t read about your money, your money will not take care of you”: 7 investing lessons from top fund managers

    November 17, 2026

    Betashares launches AI ETF to complete trade exposure

    November 17, 2026

    Ether Slides 26% in a Month to Test $1,700 as ETF Outflows Swell and Whales Buy — BigGo Finance

    November 17, 2026
    Most Popular

    🔥Juve target Chukwuemeka, Inter raise funds, Elmas bid in play 🤑

    August 20, 2025

    💵 Libra responds after Flamengo takes legal action and ‘freezes’ funds

    September 26, 2025

    🇮🇸 CPP Investments and Equinix complete atNorth acquisition to support growth of leading Nordic data center platform

    September 1, 2026
    © 2026 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.